Immediate Impact

49 standout
Sub-graph 1 of 22

Citing Papers

Cancer epigenetics: from laboratory studies and clinical trials to precision medicine
2024 Standout
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
2 intermediate papers

Works of Nigel Patton being referenced

Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML)
2016
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib
2014

Author Peers

Author Last Decade Papers Cites
Nigel Patton 101 61 81 91 82 12 266
Esperanza Tuset 87 108 56 53 73 13 238
Jeanne M. Rothberg 64 65 150 130 92 10 321
Brian D. Kueck 107 112 80 79 133 14 293
Teruaki Akaogi 148 59 47 55 58 19 324
Alessandra Crescimanno 172 57 64 70 80 14 313
P. Spaander 53 52 106 50 134 18 329
R Hoyt 124 89 89 30 111 13 296
Silvia Trappolini 150 39 47 95 77 13 282
Barbara R. Seligman 73 52 69 25 56 13 235
Nelma Clementino 247 121 44 47 66 17 335

All Works

Loading papers...

Rankless by CCL
2026